Charmacy Pharmaceutical (2289) Announces 2025 EGM and Key Resolutions

Bulletin Express

Nov 24, 2025

Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) has released a notice regarding the extraordinary general meeting (EGM) scheduled for 12 December 2025 at 3:00 p.m. The event is set to take place in the conference room on the 2nd Floor of No. 33 Liyu Street, Dongchong Town, Nansha District, Guangzhou City, Guangdong Province, PRC.

Charmacy Pharmaceutical intends to review and, if deemed appropriate, approve multiple resolutions. These include a new framework loan agreement with Jiangyao Group Co., Ltd., authorizing relevant terms related to the agreement’s loan facility. A further resolution involves granting authorization to a member of the board to determine commercial terms, sign documents, and take steps to finalize transactions under the agreement. Additional items include the proposed appointment of Pan-China Certified Public Accountants LLP as the auditors for the fiscal year ending 31 December 2025 and the proposed amendments to the company’s articles of association, rules of procedures for general meetings, and rules of procedures for board meetings.

Shareholders seeking more information are advised to refer to the circular dated 24 November 2025 for complete details on the proposed resolutions and related instructions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1132957238"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1132957238\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1132957238?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-24 19:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132957238","market":"us","top_or_hot":-1,"title":"Charmacy Pharmaceutical (2289) Announces 2025 EGM and Key Resolutions","media":"Bulletin Express","content":"<p>Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) has released a notice regarding the extraordinary general meeting (EGM) scheduled for 12 December 2025 at 3:00 p.m. The event is set to take place in the conference room on the 2nd Floor of No. 33 Liyu Street, Dongchong Town, Nansha District, Guangzhou City, Guangdong Province, PRC.</p>\n<p>Charmacy Pharmaceutical intends to review and, if deemed appropriate, approve multiple resolutions. These include a new framework loan agreement with Jiangyao Group Co., Ltd., authorizing relevant terms related to the agreement’s loan facility. A further resolution involves granting authorization to a member of the board to determine commercial terms, sign documents, and take steps to finalize transactions under the agreement. Additional items include the proposed appointment of Pan-China Certified Public Accountants LLP as the auditors for the fiscal year ending 31 December 2025 and the proposed amendments to the company’s articles of association, rules of procedures for general meetings, and rules of procedures for board meetings.</p>\n<p>Shareholders seeking more information are advised to refer to the circular dated 24 November 2025 for complete details on the proposed resolutions and related instructions.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charmacy Pharmaceutical (2289) Announces 2025 EGM and Key Resolutions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharmacy Pharmaceutical (2289) Announces 2025 EGM and Key Resolutions\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-24 19:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) has released a notice regarding the extraordinary general meeting (EGM) scheduled for 12 December 2025 at 3:00 p.m. The event is set to take place in the conference room on the 2nd Floor of No. 33 Liyu Street, Dongchong Town, Nansha District, Guangzhou City, Guangdong Province, PRC.</p>\n<p>Charmacy Pharmaceutical intends to review and, if deemed appropriate, approve multiple resolutions. These include a new framework loan agreement with Jiangyao Group Co., Ltd., authorizing relevant terms related to the agreement’s loan facility. A further resolution involves granting authorization to a member of the board to determine commercial terms, sign documents, and take steps to finalize transactions under the agreement. Additional items include the proposed appointment of Pan-China Certified Public Accountants LLP as the auditors for the fiscal year ending 31 December 2025 and the proposed amendments to the company’s articles of association, rules of procedures for general meetings, and rules of procedures for board meetings.</p>\n<p>Shareholders seeking more information are advised to refer to the circular dated 24 November 2025 for complete details on the proposed resolutions and related instructions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02289","symbol_name":"创美药业","start_time":0,"source_url":"","article_id":"1132957238","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132957238","pubTimestamp":1763984482,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) has released a notice regarding the extraordinary general meeting (EGM) scheduled for 12 December 2025 at 3:00 p.m. The event is set to take place...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02289":"创美药业"},"translate_title":"Charmacy Pharmaceutical(2289)公布2025年临时股东大会及主要决议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02289":1},"content_text":"Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) has released a notice regarding the extraordinary general meeting (EGM) scheduled for 12 December 2025 at 3:00 p.m. The event is set to take place in the conference room on the 2nd Floor of No. 33 Liyu Street, Dongchong Town, Nansha District, Guangzhou City, Guangdong Province, PRC.\nCharmacy Pharmaceutical intends to review and, if deemed appropriate, approve multiple resolutions. These include a new framework loan agreement with Jiangyao Group Co., Ltd., authorizing relevant terms related to the agreement’s loan facility. A further resolution involves granting authorization to a member of the board to determine commercial terms, sign documents, and take steps to finalize transactions under the agreement. Additional items include the proposed appointment of Pan-China Certified Public Accountants LLP as the auditors for the fiscal year ending 31 December 2025 and the proposed amendments to the company’s articles of association, rules of procedures for general meetings, and rules of procedures for board meetings.\nShareholders seeking more information are advised to refer to the circular dated 24 November 2025 for complete details on the proposed resolutions and related instructions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}